| Basics |
Haemonetics Corporation
Haemonetics Corp is a health care company. It provides products enabling in the processing, handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes.
|
| IPO Date: |
January 3, 1994 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$3.93B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.76 | 1.21%
|
| Avg Daily Range (30 D): |
$1.05 | 1.64%
|
| Avg Daily Range (90 D): |
$1.01 | 1.69%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.31M |
| Avg Daily Volume (30 D): |
.79M |
| Avg Daily Volume (90 D): |
.85M |
| Trade Size |
| Avg Trade Size (Sh.): |
82 |
| Avg Trade Size (Sh.) (30 D): |
46 |
| Avg Trade Size (Sh.) (90 D): |
49 |
| Institutional Trades |
| Total Inst.Trades: |
9,006 |
| Avg Inst. Trade: |
$2.73M |
| Avg Inst. Trade (30 D): |
$3.6M |
| Avg Inst. Trade (90 D): |
$3.49M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.85M |
| Avg Closing Trade (30 D): |
$7.9M |
| Avg Closing Trade (90 D): |
$7.41M |
| Avg Closing Volume: |
54.41K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$3.43
|
$.81
|
$.71
|
|
Diluted EPS
|
$3.42
|
$.81
|
$.7
|
|
Revenue
|
$ 1.33B
|
$ 327.32M
|
$ 321.39M
|
|
Gross Profit
|
$ 773.59M
|
$ 194.74M
|
$ 192.24M
|
|
Net Income / Loss
|
$ 168.19M
|
$ 38.68M
|
$ 34.03M
|
|
Operating Income / Loss
|
$ 242.73M
|
$ 58.49M
|
$ 53.87M
|
|
Cost of Revenue
|
$ 554.27M
|
$ 132.57M
|
$ 129.15M
|
|
Net Cash Flow
|
$ -2.86M
|
$ 3.53M
|
$ -13.87M
|
|
PE Ratio
|
24.54
|
|
|
|
|
|
